BCMIO
EW icon

Beacon Capital Management Inc (Ohio)’s Edwards Lifesciences EW Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-9
Closed – – 110
2017
Q1 		$0 Buy
+9
New +$282 ﹤0.01% 116
2014
Q2 		– Sell
-600
Closed -$7K – 241
2014
Q1 		$7K Hold
600
– – ﹤0.01% 161
2013
Q4 		$7K Buy
+600
New +$6.76K ﹤0.01% 158

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Beacon Capital Management Inc (Ohio)'s EW Position: Q2 2017 in Review

Beacon Capital Management Inc (Ohio) sold out of Edwards Lifesciences (EW) in Q2 2017, closing a stake of 9 shares.

Beacon Capital Management Inc (Ohio) first reported a position in EW in Q4 2013 and held it in 3 quarters. The position peaked at $7K in Q1 2014. 721 funds tracked by Wall St. Rank hold EW as of Q2 2017.

  • Beacon Capital Management Inc (Ohio) reported no remaining Edwards Lifesciences position as of Q2 2017 after selling out during the quarter.
  • Beacon Capital Management Inc (Ohio) sold 9 Edwards Lifesciences shares in Q2 2017.
  • Beacon Capital Management Inc (Ohio) first reported a position in Edwards Lifesciences in Q4 2013 and held it in 3 quarters.
  • Beacon Capital Management Inc (Ohio)'s Edwards Lifesciences position peaked at $7K in Q1 2014.
  • 721 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2017.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q2 2017, filed 11 Jul 2017.